US pharma giant Eli Lilly plans to introduce its blockbuster anti-diabetes drug Mounjaro to India next year, to target weight loss market
This announcement was made by CEO David Ricks in an exclusive interview with Business Today on Wednesday.
Source: businesstoday.in